Description:
MYOPATHY, CENTRONUCLEAR, 1; CNM1
TITIN; TTN
Repository
|
NIGMS Human Genetic Cell Repository
|
Subcollection |
Heritable Diseases CMD Specific PIGI Consented Sample |
Biopsy Source
|
Back
|
Cell Type
|
Fibroblast
|
Transformant
|
Untransformed
|
Race
|
White
|
Ethnicity
|
Not Hispanic/Latino
|
Country of Origin
|
USA
|
Family History
|
N
|
Relation to Proband
|
proband
|
Confirmation
|
Clinical summary/Case history
|
Species
|
Homo sapiens
|
Common Name
|
Human
|
Remarks
|
|
PDL at Freeze |
4.9 |
Passage Frozen |
2 |
|
IDENTIFICATION OF SPECIES OF ORIGIN |
Species of Origin Confirmed by LINE assay |
|
Gene |
TTN |
Chromosomal Location |
2q31.2 |
Allelic Variant 1 |
; MYOPATHY, CENTRONUCLEAR |
Identified Mutation |
c.15721+1G>A; Titin |
|
Gene |
TTN |
Chromosomal Location |
2q31.2 |
Allelic Variant 2 |
; MYOPATHY, CENTRONUCLEAR |
Identified Mutation |
c.44998_45001del (p.N22897fs) |
|
Gene |
TTN |
Chromosomal Location |
2q31.2 |
Allelic Variant 2 |
; MYOPATHY, CENTRONUCLEAR |
Identified Mutation |
c.106244delG (p.G32772fs) |
Demographic Data |
Relation to Proband |
proband |
Age at Sampling |
8 YR |
Sex |
Male |
Age of Onset(If not a control) |
6 MO |
Hispanic or Latino/Not Hispanic or Latino |
Not Hispanic/Latino |
Racial Category |
White |
Country |
USA |
|
Data Elements |
Clinical Element Type: General NIGMS Catalog Remarks |
(Baseline) |
Mutation Information |
Gene, variant, consequence, and exon number: |
TTN, C.15721+G>A, SPLICING, INTRON 52 |
Zygosity: |
Heterozygous |
Other variants: |
TTN, C.44998_45001DEL (P.N22897FS), FRAMESHIFT, EXON 326
TTN, C.106244DELG (P.G32772FS), FRAMESHIFT, EXON 358 |
Age of Symptom Onset and Age at Diagnosis |
Age of Symptom Onset: |
6 MONTHS |
In Utero History Information |
|
Decreased fetal movement
|
Birth History Information |
|
|
Additional Information: |
MUSCLE WEAKNESS
DECREASED RESPIRATION |
Dysmorphic Features |
|
|
Neurological Symptoms |
|
|
Optical and Audiological Symptoms |
|
|
Musculoskeletal Symptoms |
|
|
Developmental Milestones |
|
|
Holding Head Up Without Assistance: |
Not achieved and not maintained |
Sitting Without Assistance: |
Achieved and maintained |
Walking Without Assistance: |
Not achieved and not maintained |
Running: |
Not achieved and not maintained |
Gastrointestinal Symptoms |
|
|
Additional Information: |
COMBINED ORAL AND G-TUBE FEEDING |
Genitourinary Symptoms |
|
|
Respiratory and Cardiovascular Symptoms |
|
|
Additional Information: |
PULMONARY ASPIRATION |
Cognitive and Behavioral Symptoms |
|
|
Additional Information |
Testing Performed |
Neurological Testing: |
NERVE CONDUCTION VELOCITY: MYOPATHIC
ELECTROMYOGRAPHY: MYOPATHIC
DEEP TENDON REFLEXES: ABSENT
MRI: NORMAL |
Musculoskeletal and Developmental Testing: |
MUSCLE BIOPSY: CENTRAL NUCLEI, FIBER SIZE VARIATION |
Treatments and Assistive Devices |
|
|
Additional Testing: |
USE RESPIRATORY SUPPORT ALL NIGHTS, WHEN ILL OR IN ANTICIPATION OF SURGERY |
Medications |
Family History |
Remarks |
Clinically affected; symptom onset during first 6 months of life; presentation in utero with decreased fetal movements, muscle weakness/decreased respiration at birth; facial weakness; high-arched palate; scoliosis; maximum motor function ever achieved: sit when placed; current motor function: sit when placed; motor functions never achieved: holding head up without assistance, walking without assistance, or running; normal cognitive ability; diagnosis of centronuclear myopathy confirmed by muscle biopsy, skin biopsy, and genetic testing; myopathic nerve conduction velocity; myopathic EMG; absent deep tendon reflexes; biopsy at 3 months of age revealed central nuclei and fiber size variation but no type I fiber predominance and no increase in connective tissue or endomysial tissue; Sanger sequencing revealed compound heterozygous mutation in the TTN gene: c.15721+1G>A (full-length titin, NM_001267550.1) on intron 52 of the paternal allele - a predicted splice site variant, c.44998_45001del and c.106244delG frameshift mutations on the maternal allele; normal MRI/CT scan; normal echo; no ocular, cardiac or brain involvement; management: at 5 years, needed pulmonary aspiration and used oxygen support during the day, had combined oral and G-tube feeding since infancy; no trach tube; no family history of disease; subject is 979-1 in Neurology (2013) 81:1-10, PMID:23975875. |
Ceyhan-Birsoy O, Agrawal PB, Hidalgo C, Schmitz-Abe K, DeChene ET, Swanson LC, Soemedi R, Vasli N, Iannaccone ST, Shieh PB, Shur N, Dennison JM, Lawlor MW, Laporte J, Markianos K, Fairbrother WG, Granzier H, Beggs AH, Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathy Neurology81:1205-14 2013 |
PubMed ID: 23975875 |
Cumulative PDL at Freeze |
4.9 |
Passage Frozen |
2 |
Split Ratio |
1:2 |
Temperature |
37 C |
Percent CO2 |
5% |
Percent O2 |
3% |
Medium |
Eagles Minimum Essential Medium with Earle's salts:Dulbecco's modified MEM with 2mM L-glutamine or equivalent |
Serum |
15% fetal bovine serum Not inactivated |
Supplement |
- |
|
|